PBI10 BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE

Abstract

Authors

T. Abbott C. Balmaceda M.A. Espinoza

Full Text Cite This Article
Back to Volume 23, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×